April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Ajay Major: PFS benefit in AMPLIFY Phase III trial in CLL
Jul 31, 2024, 11:52

Ajay Major: PFS benefit in AMPLIFY Phase III trial in CLL

Ajay Major, Lymphoma Faculty at the CU School of Medicine, shared on X:

“Press release now out: PFS benefit in AMPLIFY Phase III trial of fixed-duration acala + venetoclax +/- obinutuzumab vs investigator choice of CIT. Would be great to have a 2nd-gen BTKi plus ven time-limited combo approved.”

Read further.
Source: Ajay Major/X